Insiders · Profile

Landis G. Michael

Chief Financial Officer at Polaryx Therapeutics. Filing since 18 Feb 2026. CIK 0001548560

Company

Date

Role

Action

Amount

Of holding

18 Feb 2026

Chief Financial Officer

Bought

2,867

$7.99K

1.3%

1 decision on file.